Literature DB >> 6487981

Polyamines in colorectal cancer.

A N Kingsnorth, A B Lumsden, H M Wallace.   

Abstract

Polyamine levels (putrescine, spermidine and spermine) in colorectal cancers (n = 25) were measured in order to assess their importance as markers of cellular proliferation. Colonic mucosa from healthy resection margins of patients with diverticular disease (n = 5) was used as control material. Polyamine levels (expressed as nanomoles per 100 mg tumour) in cancers ranged from 0.8 to 7.9 for putrescine (mean: 2.3 +/- 0.7), from 6.5 to 22.8 for spermidine (mean: 13.9 +/- 0.9) and from 13.0 to 37.5 for spermine (mean: 22.1 +/- 1.3). Mean spermidine and spermine content of cancers was more than three times mean spermidine (3.92 +/- 0.8), and more than four times mean spermine (5.0 +/- 1.2), content of normal colonic mucosa (P less than 0.01). Polyamine content of colorectal cancers was independent of tumour site, Dukes' stage, histological grade and the presence of palpable liver metastases at laparotomy. Because colorectal cancers contain such high levels of spermidine and spermine, polyamines may play an essential role in the regulation of their growth.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487981     DOI: 10.1002/bjs.1800711019

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  23 in total

Review 1.  A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia.

Authors:  J T Cross; E M Poole; C M Ulrich
Journal:  Pharmacogenomics J       Date:  2008-01-15       Impact factor: 3.550

Review 2.  Polyamines in gastrointestinal cancer.

Authors:  R Saydjari; C M Townsend; S C Barranco; J C Thompson
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

Review 3.  The chemotherapeutic potential of polyamine antimetabolites.

Authors:  A N Kingsnorth
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

4.  Characterization of putrescine- and spermidine-transport systems of a rat pancreatic acinar tumoral cell line (AR4-2J).

Authors:  T G Nicolet; J L Scemama; L Pradayrol; C Seva; N Vaysse
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

5.  Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colorectal cancer cells.

Authors:  Alun Hughes; Nicholas I Smith; Heather M Wallace
Journal:  Biochem J       Date:  2003-09-01       Impact factor: 3.857

6.  Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis.

Authors:  Francis M Giardiello; Robert A Casero; Stanley R Hamilton; Linda M Hylind; Jill D Trimbath; Deborah E Geiman; Katharine R Judge; Walter Hubbard; G Johan A Offerhaus; Vincent W Yang
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

7.  Changes in polyamine catabolism in HL-60 human promyelogenous leukaemic cells in response to etoposide-induced apoptosis.

Authors:  G S Lindsay; H M Wallace
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

Review 8.  A perspective of polyamine metabolism.

Authors:  Heather M Wallace; Alison V Fraser; Alun Hughes
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

9.  Genetic polymorphism in ornithine decarboxylase and risk of breast cancer.

Authors:  Iain Brown; Susan Halliday; Heather Greig; Steven D Heys; Heather M Wallace; Andrew C Schofield
Journal:  Fam Cancer       Date:  2009-02-19       Impact factor: 2.375

10.  Induction of apoptosis in human leukaemic cells by IPENSpm, a novel polyamine analogue and anti-metabolite.

Authors:  Alison V Fraser; Patrick M Woster; Heather M Wallace
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.